Sanofi caps insulin costs at $35 nationwide
“No one should struggle to afford their insulin,” said Adam Gluck, Head of U.S. Corporate Affairs at Sanofi.
Sanofi
Sanofi completes acquisition of Blueprint Medicines
The acquisition of Blueprint brings Sanofi an established presence among allergists, dermatologists, and immunologists which is expected to enhance Sanofi’s ability to advance its growing immunology pipeline.